Aster Capital Management (Difc) LTD Exact Sciences Corp Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 83 shares of EXAS stock, worth $4,092. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83
Previous 11,099
99.25%
Holding current value
$4,092
Previous $756 Million
99.38%
% of portfolio
0.0%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding EXAS
# of Institutions
683Shares Held
163MCall Options Held
3.42MPut Options Held
2.34M-
Capital World Investors Los Angeles, CA17.5MShares$865 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$839 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$595 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$595 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$307 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.73B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...